Loading…
Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests
Background: Bronchial provocation tests such as exercise, methacholine (MCH), and adenosine-5′-monophosphate (AMP) challenges are used extensively in the diagnosis of asthma. A study was undertaken to determine whether exhaled nitric oxide (eNO) can be used to diagnose asthma in patients with non-sp...
Saved in:
Published in: | Thorax 2005-05, Vol.60 (5), p.383-388 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-b522t-78b3b7778a1f31c9de0b1a20f9010c5e64cdd8bb1900ae1fde5c45120fd154e03 |
---|---|
cites | |
container_end_page | 388 |
container_issue | 5 |
container_start_page | 383 |
container_title | Thorax |
container_volume | 60 |
creator | Berkman, N Avital, A Breuer, R Bardach, E Springer, C Godfrey, S |
description | Background: Bronchial provocation tests such as exercise, methacholine (MCH), and adenosine-5′-monophosphate (AMP) challenges are used extensively in the diagnosis of asthma. A study was undertaken to determine whether exhaled nitric oxide (eNO) can be used to diagnose asthma in patients with non-specific respiratory symptoms and to compare this test with conventional provocation tests. Methods: Patients with non-specific respiratory symptoms and normal spirometric parameters were included in the study. eNO was measured and exercise, MCH and AMP challenges performed in all subjects. Patients were defined as asthmatic based on clinical follow up 24 months after testing. Results: Forty patients were considered asthmatic and 45 were not. The area under receiver operating characteristic curves gave values of 0.896 for eNO, 0.781 for exercise, 0.924 for MCH, and 0.939 for AMP (p = 0.033, 0.575 and 0.085 for eNO v exercise, MCH and AMP respectively). From our data, a cut off value of NO >7 ppb at a flow rate of 250 ml/s best differentiates between asthmatics and non-asthmatics (sensitivity 82.5%, specificity 88.9%). Optimal cut off values for other tests were exercise: ΔFEV1 ⩾10% (sensitivity 57.9%, specificity 100%); PC20-MCH: ⩽3 mg/ml (sensitivity 87.5%, specificity 86.7%); and PC20-AMP: ⩽150 mg/ml (sensitivity 89.5%, specificity 95.6%). Conclusions: Measurement of eNO can be used as a safe, simple and rapid test for the diagnosis of asthma and is as good as bronchial provocation tests. |
doi_str_mv | 10.1136/thx.2004.031104 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1758892</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4026836941</sourcerecordid><originalsourceid>FETCH-LOGICAL-b522t-78b3b7778a1f31c9de0b1a20f9010c5e64cdd8bb1900ae1fde5c45120fd154e03</originalsourceid><addsrcrecordid>eNqFkc2LFDEUxIMo7rh69iYB0YPQs3n9kaQ9CDKsrrD4AepBhPA6nd7O2J2MSWYd_3uzzrCrXjy9Q_1eUUUR8hDYEqDiJ2ncLUvG6iWrAFh9iyyg5rKoypbfJosssIJXgh-RezGuGWMSQNwlR9BIzgRUC_L1dDfiZHrqbApWU7-zvaHW0TQa2lu8cD7aSP1AMaZxxudU-3mDwUbv6A-bRtoF7_RocaKb4C-9xmSzlExM8T65M-AUzYPDPSafXp1-XJ0V5-9ev1m9PC-6pixTIWRXdUIIiTBUoNvesA6wZEPLgOnG8Fr3vew6aBlDA0NvGl03kIEemtqw6pi82Ptutt1sem1cCjipTbAzhp_Ko1V_K86O6sJfKhCNlG2ZDZ4eDIL_vs3R1WyjNtOEzvhtVFyItpQtz-Djf8C13waXy2UvCYJDWYpMnewpHXyMwQzXUYCpq91U3k1d7ab2u-WPR382uOEPQ2XgyQHAqHEaAjpt4w3HZc3Fb6Niz9mYzO5ax_Atl6hEo95-XqkPQr6vz77UapX5Z3u-m9f_TfkLVZW-ew</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781761227</pqid></control><display><type>article</type><title>Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests</title><source>PubMed Central</source><creator>Berkman, N ; Avital, A ; Breuer, R ; Bardach, E ; Springer, C ; Godfrey, S</creator><creatorcontrib>Berkman, N ; Avital, A ; Breuer, R ; Bardach, E ; Springer, C ; Godfrey, S</creatorcontrib><description>Background: Bronchial provocation tests such as exercise, methacholine (MCH), and adenosine-5′-monophosphate (AMP) challenges are used extensively in the diagnosis of asthma. A study was undertaken to determine whether exhaled nitric oxide (eNO) can be used to diagnose asthma in patients with non-specific respiratory symptoms and to compare this test with conventional provocation tests. Methods: Patients with non-specific respiratory symptoms and normal spirometric parameters were included in the study. eNO was measured and exercise, MCH and AMP challenges performed in all subjects. Patients were defined as asthmatic based on clinical follow up 24 months after testing. Results: Forty patients were considered asthmatic and 45 were not. The area under receiver operating characteristic curves gave values of 0.896 for eNO, 0.781 for exercise, 0.924 for MCH, and 0.939 for AMP (p = 0.033, 0.575 and 0.085 for eNO v exercise, MCH and AMP respectively). From our data, a cut off value of NO >7 ppb at a flow rate of 250 ml/s best differentiates between asthmatics and non-asthmatics (sensitivity 82.5%, specificity 88.9%). Optimal cut off values for other tests were exercise: ΔFEV1 ⩾10% (sensitivity 57.9%, specificity 100%); PC20-MCH: ⩽3 mg/ml (sensitivity 87.5%, specificity 86.7%); and PC20-AMP: ⩽150 mg/ml (sensitivity 89.5%, specificity 95.6%). Conclusions: Measurement of eNO can be used as a safe, simple and rapid test for the diagnosis of asthma and is as good as bronchial provocation tests.</description><identifier>ISSN: 0040-6376</identifier><identifier>EISSN: 1468-3296</identifier><identifier>DOI: 10.1136/thx.2004.031104</identifier><identifier>PMID: 15860713</identifier><identifier>CODEN: THORA7</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Thoracic Society</publisher><subject>adenosine 5′-monophosphate ; adenosine 5′-monophosphate (AMP) ; Adenosine Monophosphate - analysis ; Adult ; Airway management ; AMP ; Asthma ; Asthma - diagnosis ; Biological and medical sciences ; Breath Tests ; Bronchial Provocation Tests - methods ; Bronchoconstrictor Agents ; Chronic obstructive pulmonary disease, asthma ; diagnosis ; eNO ; exercise ; Exercise Test ; exhaled nitric oxide ; Female ; FEV1 ; Follow-Up Studies ; Forced Expiratory Volume - physiology ; forced expiratory volume in 1 second ; forced vital capacity ; FVC ; Humans ; Male ; MCH ; Medical sciences ; methacholine ; Methacholine Chloride ; Nitric oxide ; Nitric Oxide - analysis ; Patients ; Pneumology ; Retrospective Studies ; Statistics, Nonparametric ; Steroids ; Vital Capacity - physiology</subject><ispartof>Thorax, 2005-05, Vol.60 (5), p.383-388</ispartof><rights>Copyright 2005 Thorax</rights><rights>2005 INIST-CNRS</rights><rights>Copyright: 2005 Copyright 2005 Thorax</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b522t-78b3b7778a1f31c9de0b1a20f9010c5e64cdd8bb1900ae1fde5c45120fd154e03</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1758892/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1758892/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16846704$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15860713$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Berkman, N</creatorcontrib><creatorcontrib>Avital, A</creatorcontrib><creatorcontrib>Breuer, R</creatorcontrib><creatorcontrib>Bardach, E</creatorcontrib><creatorcontrib>Springer, C</creatorcontrib><creatorcontrib>Godfrey, S</creatorcontrib><title>Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests</title><title>Thorax</title><addtitle>Thorax</addtitle><description>Background: Bronchial provocation tests such as exercise, methacholine (MCH), and adenosine-5′-monophosphate (AMP) challenges are used extensively in the diagnosis of asthma. A study was undertaken to determine whether exhaled nitric oxide (eNO) can be used to diagnose asthma in patients with non-specific respiratory symptoms and to compare this test with conventional provocation tests. Methods: Patients with non-specific respiratory symptoms and normal spirometric parameters were included in the study. eNO was measured and exercise, MCH and AMP challenges performed in all subjects. Patients were defined as asthmatic based on clinical follow up 24 months after testing. Results: Forty patients were considered asthmatic and 45 were not. The area under receiver operating characteristic curves gave values of 0.896 for eNO, 0.781 for exercise, 0.924 for MCH, and 0.939 for AMP (p = 0.033, 0.575 and 0.085 for eNO v exercise, MCH and AMP respectively). From our data, a cut off value of NO >7 ppb at a flow rate of 250 ml/s best differentiates between asthmatics and non-asthmatics (sensitivity 82.5%, specificity 88.9%). Optimal cut off values for other tests were exercise: ΔFEV1 ⩾10% (sensitivity 57.9%, specificity 100%); PC20-MCH: ⩽3 mg/ml (sensitivity 87.5%, specificity 86.7%); and PC20-AMP: ⩽150 mg/ml (sensitivity 89.5%, specificity 95.6%). Conclusions: Measurement of eNO can be used as a safe, simple and rapid test for the diagnosis of asthma and is as good as bronchial provocation tests.</description><subject>adenosine 5′-monophosphate</subject><subject>adenosine 5′-monophosphate (AMP)</subject><subject>Adenosine Monophosphate - analysis</subject><subject>Adult</subject><subject>Airway management</subject><subject>AMP</subject><subject>Asthma</subject><subject>Asthma - diagnosis</subject><subject>Biological and medical sciences</subject><subject>Breath Tests</subject><subject>Bronchial Provocation Tests - methods</subject><subject>Bronchoconstrictor Agents</subject><subject>Chronic obstructive pulmonary disease, asthma</subject><subject>diagnosis</subject><subject>eNO</subject><subject>exercise</subject><subject>Exercise Test</subject><subject>exhaled nitric oxide</subject><subject>Female</subject><subject>FEV1</subject><subject>Follow-Up Studies</subject><subject>Forced Expiratory Volume - physiology</subject><subject>forced expiratory volume in 1 second</subject><subject>forced vital capacity</subject><subject>FVC</subject><subject>Humans</subject><subject>Male</subject><subject>MCH</subject><subject>Medical sciences</subject><subject>methacholine</subject><subject>Methacholine Chloride</subject><subject>Nitric oxide</subject><subject>Nitric Oxide - analysis</subject><subject>Patients</subject><subject>Pneumology</subject><subject>Retrospective Studies</subject><subject>Statistics, Nonparametric</subject><subject>Steroids</subject><subject>Vital Capacity - physiology</subject><issn>0040-6376</issn><issn>1468-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqFkc2LFDEUxIMo7rh69iYB0YPQs3n9kaQ9CDKsrrD4AepBhPA6nd7O2J2MSWYd_3uzzrCrXjy9Q_1eUUUR8hDYEqDiJ2ncLUvG6iWrAFh9iyyg5rKoypbfJosssIJXgh-RezGuGWMSQNwlR9BIzgRUC_L1dDfiZHrqbApWU7-zvaHW0TQa2lu8cD7aSP1AMaZxxudU-3mDwUbv6A-bRtoF7_RocaKb4C-9xmSzlExM8T65M-AUzYPDPSafXp1-XJ0V5-9ev1m9PC-6pixTIWRXdUIIiTBUoNvesA6wZEPLgOnG8Fr3vew6aBlDA0NvGl03kIEemtqw6pi82Ptutt1sem1cCjipTbAzhp_Ko1V_K86O6sJfKhCNlG2ZDZ4eDIL_vs3R1WyjNtOEzvhtVFyItpQtz-Djf8C13waXy2UvCYJDWYpMnewpHXyMwQzXUYCpq91U3k1d7ab2u-WPR382uOEPQ2XgyQHAqHEaAjpt4w3HZc3Fb6Niz9mYzO5ax_Atl6hEo95-XqkPQr6vz77UapX5Z3u-m9f_TfkLVZW-ew</recordid><startdate>20050501</startdate><enddate>20050501</enddate><creator>Berkman, N</creator><creator>Avital, A</creator><creator>Breuer, R</creator><creator>Bardach, E</creator><creator>Springer, C</creator><creator>Godfrey, S</creator><general>BMJ Publishing Group Ltd and British Thoracic Society</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><general>BMJ Group</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20050501</creationdate><title>Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests</title><author>Berkman, N ; Avital, A ; Breuer, R ; Bardach, E ; Springer, C ; Godfrey, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b522t-78b3b7778a1f31c9de0b1a20f9010c5e64cdd8bb1900ae1fde5c45120fd154e03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>adenosine 5′-monophosphate</topic><topic>adenosine 5′-monophosphate (AMP)</topic><topic>Adenosine Monophosphate - analysis</topic><topic>Adult</topic><topic>Airway management</topic><topic>AMP</topic><topic>Asthma</topic><topic>Asthma - diagnosis</topic><topic>Biological and medical sciences</topic><topic>Breath Tests</topic><topic>Bronchial Provocation Tests - methods</topic><topic>Bronchoconstrictor Agents</topic><topic>Chronic obstructive pulmonary disease, asthma</topic><topic>diagnosis</topic><topic>eNO</topic><topic>exercise</topic><topic>Exercise Test</topic><topic>exhaled nitric oxide</topic><topic>Female</topic><topic>FEV1</topic><topic>Follow-Up Studies</topic><topic>Forced Expiratory Volume - physiology</topic><topic>forced expiratory volume in 1 second</topic><topic>forced vital capacity</topic><topic>FVC</topic><topic>Humans</topic><topic>Male</topic><topic>MCH</topic><topic>Medical sciences</topic><topic>methacholine</topic><topic>Methacholine Chloride</topic><topic>Nitric oxide</topic><topic>Nitric Oxide - analysis</topic><topic>Patients</topic><topic>Pneumology</topic><topic>Retrospective Studies</topic><topic>Statistics, Nonparametric</topic><topic>Steroids</topic><topic>Vital Capacity - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berkman, N</creatorcontrib><creatorcontrib>Avital, A</creatorcontrib><creatorcontrib>Breuer, R</creatorcontrib><creatorcontrib>Bardach, E</creatorcontrib><creatorcontrib>Springer, C</creatorcontrib><creatorcontrib>Godfrey, S</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Thorax</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berkman, N</au><au>Avital, A</au><au>Breuer, R</au><au>Bardach, E</au><au>Springer, C</au><au>Godfrey, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests</atitle><jtitle>Thorax</jtitle><addtitle>Thorax</addtitle><date>2005-05-01</date><risdate>2005</risdate><volume>60</volume><issue>5</issue><spage>383</spage><epage>388</epage><pages>383-388</pages><issn>0040-6376</issn><eissn>1468-3296</eissn><coden>THORA7</coden><abstract>Background: Bronchial provocation tests such as exercise, methacholine (MCH), and adenosine-5′-monophosphate (AMP) challenges are used extensively in the diagnosis of asthma. A study was undertaken to determine whether exhaled nitric oxide (eNO) can be used to diagnose asthma in patients with non-specific respiratory symptoms and to compare this test with conventional provocation tests. Methods: Patients with non-specific respiratory symptoms and normal spirometric parameters were included in the study. eNO was measured and exercise, MCH and AMP challenges performed in all subjects. Patients were defined as asthmatic based on clinical follow up 24 months after testing. Results: Forty patients were considered asthmatic and 45 were not. The area under receiver operating characteristic curves gave values of 0.896 for eNO, 0.781 for exercise, 0.924 for MCH, and 0.939 for AMP (p = 0.033, 0.575 and 0.085 for eNO v exercise, MCH and AMP respectively). From our data, a cut off value of NO >7 ppb at a flow rate of 250 ml/s best differentiates between asthmatics and non-asthmatics (sensitivity 82.5%, specificity 88.9%). Optimal cut off values for other tests were exercise: ΔFEV1 ⩾10% (sensitivity 57.9%, specificity 100%); PC20-MCH: ⩽3 mg/ml (sensitivity 87.5%, specificity 86.7%); and PC20-AMP: ⩽150 mg/ml (sensitivity 89.5%, specificity 95.6%). Conclusions: Measurement of eNO can be used as a safe, simple and rapid test for the diagnosis of asthma and is as good as bronchial provocation tests.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Thoracic Society</pub><pmid>15860713</pmid><doi>10.1136/thx.2004.031104</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0040-6376 |
ispartof | Thorax, 2005-05, Vol.60 (5), p.383-388 |
issn | 0040-6376 1468-3296 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1758892 |
source | PubMed Central |
subjects | adenosine 5′-monophosphate adenosine 5′-monophosphate (AMP) Adenosine Monophosphate - analysis Adult Airway management AMP Asthma Asthma - diagnosis Biological and medical sciences Breath Tests Bronchial Provocation Tests - methods Bronchoconstrictor Agents Chronic obstructive pulmonary disease, asthma diagnosis eNO exercise Exercise Test exhaled nitric oxide Female FEV1 Follow-Up Studies Forced Expiratory Volume - physiology forced expiratory volume in 1 second forced vital capacity FVC Humans Male MCH Medical sciences methacholine Methacholine Chloride Nitric oxide Nitric Oxide - analysis Patients Pneumology Retrospective Studies Statistics, Nonparametric Steroids Vital Capacity - physiology |
title | Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T03%3A47%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exhaled%20nitric%20oxide%20in%20the%20diagnosis%20of%20asthma:%20comparison%20with%20bronchial%20provocation%20tests&rft.jtitle=Thorax&rft.au=Berkman,%20N&rft.date=2005-05-01&rft.volume=60&rft.issue=5&rft.spage=383&rft.epage=388&rft.pages=383-388&rft.issn=0040-6376&rft.eissn=1468-3296&rft.coden=THORA7&rft_id=info:doi/10.1136/thx.2004.031104&rft_dat=%3Cproquest_pubme%3E4026836941%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b522t-78b3b7778a1f31c9de0b1a20f9010c5e64cdd8bb1900ae1fde5c45120fd154e03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1781761227&rft_id=info:pmid/15860713&rfr_iscdi=true |